Neurotensin: peptide for the next millennium.
Neurotensin is an endogenous tridecapeptide neurotransmitter (pGlu-Leu-Tyr-Glu-Asn-Lys-Pro-Arg-Arg-Pro-Try-Ile-Leu-OH) that was discovered by Carraway and Leeman in bovine hypothalami in the early 1970s. Since then this peptide has been the subject of a multitude of articles detailing discoveries related to its activity, receptors, localization, synthesis, and interactions with other systems. This review article does not intend to summarize again all the history of this fascinating peptide and its receptors, since this has been done quite well by others. The reader will be directed to these other reviews, where appropriate. Instead, this review attempts to provide a summary of current knowledge about neurotensin, why it is an important peptide to study, and where the field is heading. Special emphasis is placed on the behavioral studies, particularly with reference to agonists, antagonists, and antisense studies, as well as, the interaction of neurotensin with other neurotransmitters.
Tyler-McMahon
B M
BM
Laboratory of Neuropharmacology, Mayo Foundation for Medical and Educational Research, 4500 San Pablo Rd., 32224, Jacksonville, FL, USA. mcmahon.beth@mayo.edu
Boules
M
M
Richelson
E
E
D000818:Animals; D001812:Blood-Brain Barrier; D002417:Cattle; D004298:Dopamine / Q000378:metabolism; D006801:Humans; D007030:Hypothalamo-Hypophyseal System / Q000378:metabolism; D007031:Hypothalamus; D009496:Neurotensin / Q000031:analogs & derivatives / Q000037:antagonists & inhibitors / Q000378:metabolism / Q000502:physiology*; D016376:Oligonucleotides, Antisense; D010913:Pituitary-Adrenal System / Q000378:metabolism; D018028:Receptors, Neurotensin / Q000235:genetics; D012559:Schizophrenia / Q000378:metabolism; D013329:Structure-Activity Relationship
D016376:Oligonucleotides, Antisense; D018028:Receptors, Neurotensin; D009496:Neurotensin; D004298:Dopamine